29 results
Prosecution First Blog
Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd. Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd.
February 9, 2024
Event
Obviousness–Type Double Patenting, PTA, and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect Obviousness–Type Double Patenting, PTA, and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect
January 11, 2024
Webinar
Event
Obviousness – Type Double Patenting, PTA and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect Obviousness – Type Double Patenting, PTA and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect
October 16, 2023
Webinar
Articles
Justices Could Prompt a Seismic Shift in Double Patenting Justices Could Prompt a Seismic Shift in Double Patenting
August 16, 2022
Law360Prosecution First Blog
The CCPA’s Influence on Obviousness-Type Double Patenting Jurisprudence The CCPA’s Influence on Obviousness-Type Double Patenting Jurisprudence
August 12, 2022
At the PTAB Blog
How Sweet It Smells: Examiner Rejection of Composition Claims Reversed How Sweet It Smells: Examiner Rejection of Composition Claims Reversed
April 6, 2022
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.